Further, our findings in this study provide insights into immunosuppressive mechanisms in the tumor microenvironment, where IRAK3 serves as a key regulator for signal transduction, antigen presentation, inflammatory response, and response to ICB therapy. The gene discussed is IRAK3; the disease is neoplasm.